These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26490068)

  • 1. [Effect of Kv1.3 and KCa3.1 potassium ion channels on the proliferation and migration of monocytes/macrophages].
    Zhang SX; Wang XP; Gao CY; Ju CH; Zhu LJ; DU YM
    Sheng Li Xue Bao; 2015 Oct; 67(5):505-12. PubMed ID: 26490068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockage of K(Ca)3.1 and Kv1.3 channels of the B lymphocyte decreases the inflammatory monocyte chemotaxis.
    Zhang S; Wang X; Ju C; Zhu L; Du Y; Gao C
    Int Immunopharmacol; 2016 Feb; 31():266-71. PubMed ID: 26795234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
    Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.
    Chang SC; Huq R; Chhabra S; Beeton C; Pennington MW; Smith BJ; Norton RS
    FEBS J; 2015 Jun; 282(12):2247-59. PubMed ID: 25864722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of Kv1.3 channels ameliorates radiation-induced brain injury.
    Peng Y; Lu K; Li Z; Zhao Y; Wang Y; Hu B; Xu P; Shi X; Zhou B; Pennington M; Chandy KG; Tang Y
    Neuro Oncol; 2014 Apr; 16(4):528-39. PubMed ID: 24305723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3.
    Pennington MW; Harunur Rashid M; Tajhya RB; Beeton C; Kuyucak S; Norton RS
    FEBS Lett; 2012 Nov; 586(22):3996-4001. PubMed ID: 23063513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kv1.3 channel blockade enhances the phagocytic function of RAW264.7 macrophages.
    Zhu H; Yan L; Gu J; Hao W; Cao J
    Sci China Life Sci; 2015 Sep; 58(9):867-75. PubMed ID: 26354506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role and mechanism of K
    Ma XZ; Pang ZD; Wang JH; Song Z; Zhao LM; Du XJ; Deng XL
    Exp Cell Res; 2018 Aug; 369(2):208-217. PubMed ID: 29792849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of candesartan on KCa3.1 potassium channel expression and cell culture and proliferation in peripheral blood CD4
    Li H; Zhao JL; Zhang YM; Han SX
    Clin Exp Hypertens; 2018; 40(4):303-311. PubMed ID: 29388859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
    Hansen LK
    Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of T-lymphocyte KCa3.1 and Kv1.3 channels as novel immunosuppression strategy to prevent kidney allograft rejection.
    Grgic I; Wulff H; Eichler I; Flothmann C; Köhler R; Hoyer J
    Transplant Proc; 2009; 41(6):2601-6. PubMed ID: 19715983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity and selectivity of ShK toxin for the Kv1 potassium channels from free energy simulations.
    Rashid MH; Kuyucak S
    J Phys Chem B; 2012 Apr; 116(16):4812-22. PubMed ID: 22480371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation.
    Beeton C; Smith BJ; Sabo JK; Crossley G; Nugent D; Khaytin I; Chi V; Chandy KG; Pennington MW; Norton RS
    J Biol Chem; 2008 Jan; 283(2):988-97. PubMed ID: 17984097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of blocking voltage-dependent potassium channel 1.3 on human monocyte-derived macrophage differentiation into foam cells.
    Lei XJ; Ma AQ; Xi YT; Zhang W; Yao Y; Du Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):257-61. PubMed ID: 16778967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
    Koshy S; Wu D; Hu X; Tajhya RB; Huq R; Khan FS; Pennington MW; Wulff H; Yotnda P; Beeton C
    PLoS One; 2013; 8(10):e76740. PubMed ID: 24146918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational exchange in the potassium channel blocker ShK.
    Iwakawa N; Baxter NJ; Wai DCC; Fowler NJ; Morales RAV; Sugase K; Norton RS; Williamson MP
    Sci Rep; 2019 Dec; 9(1):19307. PubMed ID: 31848433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases.
    Beeton C; Pennington MW; Norton RS
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):313-21. PubMed ID: 21824083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of KCa3.1 channels mediates adenosine regulation of the motility of human T cells.
    Chimote AA; Hajdu P; Kucher V; Boiko N; Kuras Z; Szilagyi O; Yun YH; Conforti L
    J Immunol; 2013 Dec; 191(12):6273-80. PubMed ID: 24227782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes.
    Beeton C; Wulff H; Singh S; Botsko S; Crossley G; Gutman GA; Cahalan MD; Pennington M; Chandy KG
    J Biol Chem; 2003 Mar; 278(11):9928-37. PubMed ID: 12511563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K
    Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
    Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.